Public company · Health Tech
Kenvue IPO
Consumer health company spun off from Johnson & Johnson.
Listed NYSE: KVUE HQ US Founded 2022
- Status
- listed
- Exchange
- NYSE
- Ticker
- KVUE
- Listed
- May 4, 2023
- Price range
- —
- Offer price
- $22.00
- Proceeds
- 3.80B
- Mkt cap at IPO
- —
Advisors and underwriters
| Firm | Role | Type |
|---|---|---|
| Goldman Sachs | Lead-left bookrunner | investment bank |
| J.P. Morgan | Lead bookrunner | investment bank |
| BofA Securities | Joint bookrunner | investment bank |
| Citi | Joint bookrunner | investment bank |
Timeline
-
Priced IPO
May 3, 2023
-
Listed on NYSE
May 4, 2023
Frequently asked questions
When is Kenvue expected to IPO?
Kenvue listed on May 4, 2023 on the NYSE under the ticker KVUE.
Who is leading the Kenvue IPO?
The lead bookrunner is goldman sachs. See the full advisor table on this page.